Short Course Regimens for Treatment of PKDL (Sudan)

Clinical trial NCT03399955 · UNKNOWN

Trial details

NCT number: NCT03399955
Sponsor: Drugs for Neglected Diseases
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

PKDL - Post-Kala-Azar Dermal Leishmanioid

Start date: 2018-05-09
Primary completion: 2021-05-09
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.